NRXP short interest
NRx Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 9,793,940 |
|---|---|
| Change vs prior report | 20,378 (+0.2%) |
| Change over six months | +290.0% |
| Days to cover | 13.98 (sector: 3.78) |
| Average daily volume | 700,443 |
| Rank in Healthcare | #44 of 922 by days to cover |
NRXP short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 9,793,940 | +0.2% | 13.98 | 700,443 |
| 2026-09-15 | 9,773,562 | +5.1% | 16.27 | 600,596 |
| 2026-08-31 | 9,296,173 | +7.2% | 11.69 | 795,238 |
| 2026-08-14 | 8,673,787 | +32.4% | 5.78 | 1,500,713 |
| 2026-07-31 | 6,552,631 | +5.7% | 7.59 | 863,825 |
| 2026-07-15 | 6,198,384 | +14.9% | 7.40 | 838,061 |
| 2026-06-30 | 5,396,019 | -5.5% | 5.36 | 1,007,329 |
| 2026-06-15 | 5,710,125 | +14.8% | 3.33 | 1,715,428 |
| 2026-05-29 | 4,975,572 | +6.5% | 3.02 | 1,647,375 |
| 2026-05-15 | 4,671,669 | +6.0% | 4.16 | 1,122,720 |
| 2026-04-30 | 4,407,012 | +35.6% | 3.22 | 1,368,047 |
| 2026-04-15 | 3,248,961 | +29.4% | 4.62 | 703,102 |
| 2026-03-31 | 2,511,228 | -8.7% | 2.35 | 1,069,722 |
| 2026-03-13 | 2,749,197 | +11.8% | 5.12 | 536,722 |
| 2026-02-27 | 2,459,826 | -8.4% | 4.72 | 521,313 |
| 2026-02-13 | 2,686,859 | -3.4% | 5.37 | 500,709 |
| 2026-01-30 | 2,782,413 | -21.1% | 3.78 | 735,544 |
| 2026-01-15 | 3,527,843 | +92.7% | 1.30 | 2,710,433 |
| 2025-12-31 | 1,831,090 | +4.9% | 3.29 | 555,925 |
| 2025-12-15 | 1,744,957 | +38.2% | 3.52 | 495,030 |
| 2025-11-28 | 1,262,366 | -7.1% | 2.90 | 434,759 |
| 2025-11-14 | 1,358,460 | +57.8% | 3.03 | 447,993 |
| 2025-10-31 | 860,796 | -6.0% | 1.82 | 473,222 |
| 2025-10-15 | 915,877 | +20.6% | 2.26 | 405,023 |
| 2025-09-30 | 759,569 | +11.7% | 1.90 | 400,062 |
import finzdata as yf
yf.Ticker("NRXP").short_interest # every report since 2017
yf.Client().short_interest(["NRXP"], start="2018-01-01")Healthcare short interest · NRXP price history · Who owns NRXP · All short interest